Susana Arrigain
Concepts (376)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 31 | 2023 | 617 | 2.500 |
Why?
| | Tissue Donors | 8 | 2025 | 425 | 1.190 |
Why?
| | Lung Transplantation | 10 | 2025 | 313 | 1.150 |
Why?
| | Kidney Transplantation | 10 | 2025 | 708 | 1.030 |
Why?
| | Glomerular Filtration Rate | 22 | 2023 | 746 | 0.870 |
Why?
| | Registries | 27 | 2025 | 2035 | 0.790 |
Why?
| | Tissue and Organ Procurement | 7 | 2025 | 321 | 0.780 |
Why?
| | Kidney Failure, Chronic | 11 | 2025 | 570 | 0.700 |
Why?
| | Waiting Lists | 6 | 2025 | 266 | 0.580 |
Why?
| | Organ Transplantation | 3 | 2025 | 250 | 0.540 |
Why?
| | Transplant Recipients | 5 | 2025 | 184 | 0.450 |
Why?
| | Proportional Hazards Models | 18 | 2023 | 1266 | 0.440 |
Why?
| | Graft Survival | 5 | 2025 | 535 | 0.430 |
Why?
| | Body Mass Index | 8 | 2024 | 2389 | 0.430 |
Why?
| | Middle Aged | 60 | 2025 | 33479 | 0.420 |
Why?
| | End Stage Liver Disease | 2 | 2024 | 82 | 0.400 |
Why?
| | Aged | 51 | 2025 | 23961 | 0.400 |
Why?
| | Cause of Death | 8 | 2018 | 434 | 0.390 |
Why?
| | Liver Transplantation | 3 | 2024 | 871 | 0.380 |
Why?
| | Male | 79 | 2025 | 67762 | 0.380 |
Why?
| | Resource Allocation | 2 | 2025 | 52 | 0.370 |
Why?
| | Female | 79 | 2025 | 73304 | 0.360 |
Why?
| | United States | 27 | 2025 | 14841 | 0.350 |
Why?
| | Living Donors | 6 | 2023 | 295 | 0.350 |
Why?
| | Acute Kidney Injury | 6 | 2023 | 815 | 0.340 |
Why?
| | Social Determinants of Health | 2 | 2024 | 267 | 0.330 |
Why?
| | Risk Factors | 28 | 2025 | 10388 | 0.330 |
Why?
| | Health Expenditures | 2 | 2022 | 189 | 0.310 |
Why?
| | Graft Rejection | 5 | 2024 | 624 | 0.300 |
Why?
| | Humans | 91 | 2025 | 137585 | 0.300 |
Why?
| | Aged, 80 and over | 23 | 2019 | 7635 | 0.280 |
Why?
| | Cytomegalovirus Infections | 3 | 2024 | 192 | 0.280 |
Why?
| | Ohio | 10 | 2017 | 152 | 0.280 |
Why?
| | Follow-Up Studies | 15 | 2025 | 5131 | 0.270 |
Why?
| | Adult | 37 | 2025 | 37929 | 0.270 |
Why?
| | Renal Dialysis | 7 | 2018 | 435 | 0.270 |
Why?
| | Retrospective Studies | 30 | 2025 | 15657 | 0.270 |
Why?
| | Kidney Diseases | 4 | 2011 | 408 | 0.260 |
Why?
| | Kaplan-Meier Estimate | 10 | 2021 | 889 | 0.260 |
Why?
| | Electronic Health Records | 7 | 2017 | 1069 | 0.260 |
Why?
| | Healthcare Disparities | 4 | 2025 | 654 | 0.230 |
Why?
| | Patient Navigation | 2 | 2017 | 81 | 0.230 |
Why?
| | ABO Blood-Group System | 1 | 2025 | 51 | 0.230 |
Why?
| | Health Services Accessibility | 4 | 2024 | 986 | 0.220 |
Why?
| | Treatment Outcome | 18 | 2025 | 10811 | 0.220 |
Why?
| | Time Factors | 15 | 2025 | 6828 | 0.220 |
Why?
| | Kidney | 7 | 2021 | 1468 | 0.220 |
Why?
| | Body Height | 1 | 2005 | 199 | 0.210 |
Why?
| | Knee Injuries | 1 | 2005 | 99 | 0.210 |
Why?
| | Obesity | 6 | 2024 | 2992 | 0.210 |
Why?
| | Disease Progression | 10 | 2025 | 2757 | 0.210 |
Why?
| | Nephrologists | 1 | 2023 | 13 | 0.200 |
Why?
| | Nephrology | 2 | 2021 | 61 | 0.200 |
Why?
| | Severity of Illness Index | 9 | 2024 | 2828 | 0.200 |
Why?
| | Travel | 2 | 2020 | 130 | 0.200 |
Why?
| | Informed Consent | 1 | 2024 | 175 | 0.200 |
Why?
| | Donor Selection | 2 | 2021 | 77 | 0.190 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2005 | 159 | 0.190 |
Why?
| | Nutrition Surveys | 4 | 2021 | 266 | 0.190 |
Why?
| | Risk Assessment | 11 | 2021 | 3457 | 0.190 |
Why?
| | Prognosis | 9 | 2025 | 4030 | 0.180 |
Why?
| | Stomach Diseases | 1 | 2021 | 20 | 0.180 |
Why?
| | Histamine H2 Antagonists | 1 | 2021 | 30 | 0.180 |
Why?
| | Medicare | 2 | 2024 | 773 | 0.180 |
Why?
| | Cohort Studies | 12 | 2025 | 5742 | 0.180 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.170 |
Why?
| | Insulin Resistance | 3 | 2020 | 1208 | 0.170 |
Why?
| | Proteinuria | 1 | 2021 | 97 | 0.170 |
Why?
| | Comorbidity | 8 | 2021 | 1622 | 0.170 |
Why?
| | Body Weight | 1 | 2005 | 985 | 0.170 |
Why?
| | Proton Pump Inhibitors | 1 | 2021 | 109 | 0.170 |
Why?
| | Abdominal Fat | 1 | 2020 | 41 | 0.170 |
Why?
| | Age Factors | 9 | 2021 | 3295 | 0.160 |
Why?
| | Sex Factors | 6 | 2024 | 2071 | 0.160 |
Why?
| | Ventricular Function, Left | 3 | 2019 | 534 | 0.160 |
Why?
| | Nephrectomy | 1 | 2021 | 169 | 0.160 |
Why?
| | Chi-Square Distribution | 7 | 2016 | 530 | 0.160 |
Why?
| | Magnesium | 1 | 2020 | 156 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 301 | 0.160 |
Why?
| | Hypertension | 5 | 2017 | 1295 | 0.150 |
Why?
| | Heart Transplantation | 2 | 2021 | 754 | 0.150 |
Why?
| | Career Choice | 1 | 2021 | 219 | 0.150 |
Why?
| | Internal Medicine | 1 | 2021 | 265 | 0.150 |
Why?
| | Mortality | 2 | 2018 | 362 | 0.150 |
Why?
| | Propensity Score | 5 | 2020 | 294 | 0.140 |
Why?
| | Immunologic Factors | 1 | 2020 | 236 | 0.140 |
Why?
| | Stroke Volume | 2 | 2019 | 612 | 0.140 |
Why?
| | Terminology as Topic | 1 | 2019 | 216 | 0.140 |
Why?
| | Program Evaluation | 2 | 2021 | 898 | 0.140 |
Why?
| | Gout Suppressants | 1 | 2017 | 20 | 0.140 |
Why?
| | Medicaid | 1 | 2022 | 435 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2017 | 44 | 0.140 |
Why?
| | Hypernatremia | 1 | 2017 | 8 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 114 | 0.140 |
Why?
| | Health Records, Personal | 1 | 2017 | 27 | 0.140 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 203 | 0.140 |
Why?
| | Hyponatremia | 1 | 2017 | 42 | 0.130 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 130 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 398 | 0.130 |
Why?
| | Uric Acid | 1 | 2017 | 163 | 0.130 |
Why?
| | Logistic Models | 7 | 2015 | 2074 | 0.130 |
Why?
| | Survival Rate | 5 | 2025 | 1972 | 0.130 |
Why?
| | Incidence | 6 | 2021 | 2804 | 0.120 |
Why?
| | Creatinine | 3 | 2023 | 499 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 229 | 0.120 |
Why?
| | Cardiac Surgical Procedures | 3 | 2007 | 530 | 0.120 |
Why?
| | Cytomegalovirus | 3 | 2024 | 157 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2020 | 351 | 0.120 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 294 | 0.120 |
Why?
| | Vascular Resistance | 2 | 2015 | 375 | 0.120 |
Why?
| | Contrast Media | 1 | 2018 | 467 | 0.120 |
Why?
| | Hypokalemia | 1 | 2015 | 24 | 0.120 |
Why?
| | Hyperkalemia | 1 | 2015 | 24 | 0.120 |
Why?
| | Diet, Reducing | 1 | 2015 | 89 | 0.120 |
Why?
| | Multivariate Analysis | 7 | 2016 | 1509 | 0.110 |
Why?
| | Electric Countershock | 1 | 2015 | 107 | 0.110 |
Why?
| | Catheters | 1 | 2015 | 73 | 0.110 |
Why?
| | Program Development | 2 | 2015 | 364 | 0.110 |
Why?
| | Adipokines | 1 | 2014 | 49 | 0.110 |
Why?
| | Patient Selection | 1 | 2018 | 696 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 261 | 0.110 |
Why?
| | Blood Pressure | 3 | 2017 | 1786 | 0.110 |
Why?
| | Chelating Agents | 1 | 2014 | 75 | 0.110 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 185 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 806 | 0.110 |
Why?
| | Atrial Fibrillation | 1 | 2018 | 388 | 0.110 |
Why?
| | Patient Education as Topic | 2 | 2017 | 766 | 0.110 |
Why?
| | Primary Prevention | 1 | 2015 | 196 | 0.100 |
Why?
| | Odds Ratio | 4 | 2014 | 1070 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 182 | 0.100 |
Why?
| | Lung Diseases | 1 | 2019 | 767 | 0.100 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 148 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 2 | 2010 | 69 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 333 | 0.100 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2012 | 43 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 1040 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 382 | 0.090 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 315 | 0.090 |
Why?
| | Follicular Fluid | 1 | 2011 | 5 | 0.090 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2011 | 8 | 0.090 |
Why?
| | Bicarbonates | 1 | 2011 | 44 | 0.090 |
Why?
| | Carotid Stenosis | 1 | 2012 | 91 | 0.090 |
Why?
| | Sunscreening Agents | 1 | 2011 | 25 | 0.090 |
Why?
| | Coronary Disease | 2 | 2016 | 385 | 0.090 |
Why?
| | Bariatric Surgery | 1 | 2014 | 217 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2015 | 443 | 0.090 |
Why?
| | Infertility | 1 | 2011 | 55 | 0.090 |
Why?
| | Internship and Residency | 1 | 2021 | 1147 | 0.090 |
Why?
| | Blood Flow Velocity | 1 | 2012 | 413 | 0.090 |
Why?
| | Stents | 2 | 2012 | 527 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2010 | 2531 | 0.080 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1291 | 0.080 |
Why?
| | Motivation | 1 | 2015 | 570 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 409 | 0.080 |
Why?
| | Hepatitis, Autoimmune | 1 | 2010 | 20 | 0.080 |
Why?
| | Adipose Tissue | 1 | 2014 | 635 | 0.080 |
Why?
| | Triglycerides | 1 | 2012 | 524 | 0.080 |
Why?
| | Chronic Disease | 6 | 2011 | 1793 | 0.080 |
Why?
| | Motor Activity | 1 | 2014 | 718 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2011 | 186 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.080 |
Why?
| | Health Surveys | 1 | 2011 | 514 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 354 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2014 | 642 | 0.080 |
Why?
| | Orthotic Devices | 1 | 2008 | 23 | 0.070 |
Why?
| | Young Adult | 7 | 2021 | 13209 | 0.070 |
Why?
| | Elasticity | 1 | 2009 | 197 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 622 | 0.070 |
Why?
| | Splenorenal Shunt, Surgical | 1 | 2007 | 3 | 0.070 |
Why?
| | Asthma | 1 | 2021 | 2295 | 0.070 |
Why?
| | Insurance, Health | 2 | 2022 | 283 | 0.070 |
Why?
| | Gait Disorders, Neurologic | 1 | 2008 | 46 | 0.070 |
Why?
| | Vitamin D | 1 | 2011 | 397 | 0.070 |
Why?
| | Brachial Artery | 1 | 2009 | 205 | 0.070 |
Why?
| | Mycoses | 1 | 2008 | 79 | 0.070 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 316 | 0.070 |
Why?
| | Esophageal and Gastric Varices | 1 | 2007 | 40 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1313 | 0.070 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2007 | 44 | 0.070 |
Why?
| | Diabetic Angiopathies | 1 | 2009 | 259 | 0.070 |
Why?
| | Hip Joint | 1 | 2008 | 171 | 0.060 |
Why?
| | Medical Staff | 1 | 2006 | 16 | 0.060 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2007 | 132 | 0.060 |
Why?
| | Veterans | 1 | 2018 | 1476 | 0.060 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2006 | 43 | 0.060 |
Why?
| | Staff Development | 1 | 2006 | 58 | 0.060 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1171 | 0.060 |
Why?
| | Diskectomy | 1 | 2005 | 23 | 0.060 |
Why?
| | Splanchnic Circulation | 1 | 2005 | 10 | 0.060 |
Why?
| | Survival Analysis | 4 | 2010 | 1325 | 0.060 |
Why?
| | Mesenteric Artery, Superior | 1 | 2005 | 17 | 0.060 |
Why?
| | Heart Failure | 4 | 2016 | 2236 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 92 | 0.060 |
Why?
| | Complementary Therapies | 1 | 2006 | 88 | 0.060 |
Why?
| | Intervertebral Disc | 1 | 2005 | 39 | 0.060 |
Why?
| | Adolescent | 9 | 2021 | 21513 | 0.060 |
Why?
| | Cross-Sectional Studies | 4 | 2024 | 5472 | 0.060 |
Why?
| | Intervertebral Disc Displacement | 1 | 2005 | 40 | 0.060 |
Why?
| | Prospective Studies | 5 | 2022 | 7604 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 127 | 0.060 |
Why?
| | Proctocolectomy, Restorative | 1 | 2005 | 20 | 0.060 |
Why?
| | Ileostomy | 1 | 2005 | 20 | 0.060 |
Why?
| | Health Status | 2 | 2021 | 792 | 0.060 |
Why?
| | Astrocytoma | 1 | 2006 | 128 | 0.060 |
Why?
| | Poisson Distribution | 1 | 2005 | 75 | 0.060 |
Why?
| | Hyperthermia, Induced | 1 | 2005 | 116 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2011 | 1317 | 0.060 |
Why?
| | Anterior Cruciate Ligament | 1 | 2005 | 81 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2024 | 165 | 0.050 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2005 | 121 | 0.050 |
Why?
| | Low Back Pain | 1 | 2005 | 108 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1329 | 0.050 |
Why?
| | Cardiology | 1 | 2006 | 274 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2020 | 1316 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1783 | 0.050 |
Why?
| | Waist Circumference | 2 | 2014 | 143 | 0.050 |
Why?
| | Lung | 1 | 2016 | 4060 | 0.050 |
Why?
| | Breast Diseases | 1 | 2002 | 22 | 0.050 |
Why?
| | Nipples | 1 | 2002 | 9 | 0.050 |
Why?
| | Urinalysis | 1 | 2023 | 77 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2008 | 455 | 0.050 |
Why?
| | Ambulatory Care Facilities | 2 | 2017 | 232 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1910 | 0.050 |
Why?
| | Pneumonia | 1 | 2008 | 639 | 0.050 |
Why?
| | Laboratories | 1 | 2023 | 113 | 0.050 |
Why?
| | Catheter Ablation | 1 | 2005 | 350 | 0.050 |
Why?
| | Relative Value Scales | 1 | 2021 | 5 | 0.050 |
Why?
| | Microscopy | 1 | 2023 | 152 | 0.040 |
Why?
| | Contraceptive Agents | 1 | 2022 | 66 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 2 | 2015 | 201 | 0.040 |
Why?
| | Work-Life Balance | 1 | 2021 | 22 | 0.040 |
Why?
| | ROC Curve | 3 | 2008 | 554 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 157 | 0.040 |
Why?
| | Ultrasonography, Doppler | 2 | 2015 | 124 | 0.040 |
Why?
| | Diabetes Mellitus | 3 | 2016 | 1040 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2022 | 230 | 0.040 |
Why?
| | Biomarkers | 3 | 2020 | 4149 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3556 | 0.040 |
Why?
| | United States Public Health Service | 1 | 2019 | 10 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 2031 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1289 | 0.040 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 494 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2021 | 101 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1396 | 0.040 |
Why?
| | Health Services Needs and Demand | 2 | 2015 | 273 | 0.040 |
Why?
| | Sulfonylurea Compounds | 2 | 2010 | 48 | 0.040 |
Why?
| | Mentors | 1 | 2021 | 202 | 0.040 |
Why?
| | Injections, Intra-Arterial | 1 | 2018 | 27 | 0.040 |
Why?
| | Postoperative Complications | 3 | 2006 | 2654 | 0.040 |
Why?
| | Adiposity | 2 | 2014 | 518 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 206 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 849 | 0.040 |
Why?
| | Child | 6 | 2021 | 21935 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1238 | 0.030 |
Why?
| | Acute Disease | 2 | 2010 | 1007 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2018 | 317 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 157 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 642 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2015 | 50 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 351 | 0.030 |
Why?
| | Protective Factors | 1 | 2016 | 93 | 0.030 |
Why?
| | Cystatin C | 1 | 2015 | 65 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 653 | 0.030 |
Why?
| | Child, Preschool | 3 | 2021 | 11074 | 0.030 |
Why?
| | Survivors | 2 | 2009 | 493 | 0.030 |
Why?
| | Prevalence | 2 | 2013 | 2734 | 0.030 |
Why?
| | Smoking | 2 | 2016 | 1627 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1946 | 0.030 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 92 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 147 | 0.030 |
Why?
| | Lumbosacral Region | 1 | 2015 | 58 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 307 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2006 | 431 | 0.030 |
Why?
| | Equipment Failure | 1 | 2015 | 108 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 259 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2014 | 57 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 366 | 0.030 |
Why?
| | Blood Glucose | 2 | 2015 | 2186 | 0.030 |
Why?
| | Personnel Selection | 1 | 2015 | 78 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 600 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 236 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 678 | 0.030 |
Why?
| | Phosphorus | 1 | 2014 | 97 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 69 | 0.030 |
Why?
| | Adiponectin | 1 | 2015 | 244 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1278 | 0.030 |
Why?
| | Hypogonadism | 1 | 2014 | 92 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2015 | 279 | 0.030 |
Why?
| | Glucose Metabolism Disorders | 1 | 2013 | 11 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2015 | 410 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 327 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2014 | 126 | 0.030 |
Why?
| | Life Style | 1 | 2015 | 490 | 0.030 |
Why?
| | Hyperparathyroidism | 1 | 2012 | 10 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5778 | 0.020 |
Why?
| | Hypoalbuminemia | 1 | 2012 | 30 | 0.020 |
Why?
| | Anthropometry | 1 | 2012 | 213 | 0.020 |
Why?
| | Hemoglobins | 1 | 2014 | 353 | 0.020 |
Why?
| | Body Composition | 1 | 2015 | 684 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 1167 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 176 | 0.020 |
Why?
| | Glipizide | 1 | 2010 | 6 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2199 | 0.020 |
Why?
| | Glyburide | 1 | 2010 | 32 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2002 | 2253 | 0.020 |
Why?
| | Length of Stay | 2 | 2006 | 1215 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2069 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1024 | 0.020 |
Why?
| | Heart-Lung Transplantation | 1 | 2009 | 14 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 470 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 547 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2691 | 0.020 |
Why?
| | North America | 1 | 2009 | 313 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 672 | 0.020 |
Why?
| | Europe | 1 | 2009 | 414 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1199 | 0.020 |
Why?
| | Thiazolidinediones | 1 | 2009 | 137 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 268 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2008 | 160 | 0.020 |
Why?
| | Tacrolimus | 1 | 2009 | 199 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 584 | 0.020 |
Why?
| | Quality-Adjusted Life Years | 1 | 2007 | 113 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 816 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 234 | 0.020 |
Why?
| | Dialysis | 1 | 2006 | 20 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2844 | 0.020 |
Why?
| | Salvage Therapy | 1 | 2007 | 142 | 0.020 |
Why?
| | Negativism | 1 | 2006 | 4 | 0.020 |
Why?
| | Primary Health Care | 1 | 2017 | 1738 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 522 | 0.020 |
Why?
| | Religion and Psychology | 1 | 2006 | 28 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2007 | 233 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2006 | 34 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 393 | 0.020 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 103 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2006 | 96 | 0.020 |
Why?
| | Morbidity | 1 | 2006 | 324 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2111 | 0.010 |
Why?
| | Muscle Strength | 1 | 2008 | 317 | 0.010 |
Why?
| | Gait | 1 | 2008 | 296 | 0.010 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2005 | 38 | 0.010 |
Why?
| | Metformin | 1 | 2009 | 331 | 0.010 |
Why?
| | Surgical Stapling | 1 | 2005 | 15 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 2008 | 413 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 591 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 209 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2005 | 153 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2009 | 890 | 0.010 |
Why?
| | Histological Techniques | 1 | 2004 | 40 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2008 | 660 | 0.010 |
Why?
| | Suture Techniques | 1 | 2005 | 122 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2006 | 955 | 0.010 |
Why?
| | Teaching | 1 | 2006 | 224 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 2892 | 0.010 |
Why?
| | Perioperative Care | 1 | 2005 | 178 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2010 | 951 | 0.010 |
Why?
| | Viremia | 1 | 2004 | 138 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 521 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2671 | 0.010 |
Why?
| | Papilloma | 1 | 2002 | 52 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 466 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 175 | 0.010 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2005 | 257 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2006 | 911 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 740 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2004 | 652 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1710 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1738 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2006 | 1046 | 0.010 |
Why?
| | Pneumonia, Viral | 1 | 2004 | 373 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 6763 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4193 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 2833 | 0.010 |
Why?
| | Infant | 1 | 2010 | 9465 | 0.010 |
Why?
| | Brain | 1 | 2006 | 2668 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2005 | 6079 | 0.010 |
Why?
|
|
Arrigain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|